IRIS
ROMANO, ALESSANDRA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.013
AS - Asia 3.701
EU - Europa 3.148
SA - Sud America 657
AF - Africa 566
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.094
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.776
SG - Singapore 1.611
CN - Cina 1.366
IT - Italia 1.284
IE - Irlanda 689
BR - Brasile 556
CI - Costa d'Avorio 421
UA - Ucraina 387
VN - Vietnam 218
KR - Corea 207
CA - Canada 182
RU - Federazione Russa 148
DE - Germania 128
GB - Regno Unito 110
IN - India 82
FI - Finlandia 78
SE - Svezia 77
SN - Senegal 61
AR - Argentina 48
PL - Polonia 47
MX - Messico 40
NL - Olanda 38
JP - Giappone 35
FR - Francia 28
BJ - Benin 25
ZA - Sudafrica 25
BD - Bangladesh 24
TR - Turchia 24
BE - Belgio 22
CZ - Repubblica Ceca 22
ES - Italia 19
HK - Hong Kong 19
IR - Iran 18
UZ - Uzbekistan 18
CH - Svizzera 13
EC - Ecuador 13
AT - Austria 12
CO - Colombia 10
ID - Indonesia 10
IQ - Iraq 10
MA - Marocco 10
GR - Grecia 9
IL - Israele 9
LB - Libano 9
NG - Nigeria 9
VE - Venezuela 9
LT - Lituania 8
SA - Arabia Saudita 8
DO - Repubblica Dominicana 7
AE - Emirati Arabi Uniti 6
AL - Albania 5
CL - Cile 5
NO - Norvegia 5
PE - Perù 5
PY - Paraguay 5
RO - Romania 5
AU - Australia 4
EG - Egitto 4
PK - Pakistan 4
AZ - Azerbaigian 3
BB - Barbados 3
EU - Europa 3
JO - Giordania 3
KZ - Kazakistan 3
RS - Serbia 3
TH - Thailandia 3
BF - Burkina Faso 2
BG - Bulgaria 2
DK - Danimarca 2
DZ - Algeria 2
KE - Kenya 2
LU - Lussemburgo 2
PH - Filippine 2
SI - Slovenia 2
SR - Suriname 2
TN - Tunisia 2
UY - Uruguay 2
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
GY - Guiana 1
HN - Honduras 1
LK - Sri Lanka 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PG - Papua Nuova Guinea 1
PS - Palestinian Territory 1
PT - Portogallo 1
SC - Seychelles 1
SV - El Salvador 1
TG - Togo 1
TJ - Tagikistan 1
TL - Timor Orientale 1
Totale 16.093
Salva come PNG Salva come JPEG
Città #
Dallas 1.823
Santa Clara 1.118
Singapore 875
Dublin 682
Chandler 577
Hefei 442
Jacksonville 439
Chicago 423
Abidjan 421
Houston 377
Ashburn 348
Catania 291
Boardman 290
Seoul 207
Beijing 194
Los Angeles 152
Lawrence 142
Cambridge 141
Andover 135
Nanjing 134
Toronto 116
Civitanova Marche 113
Florence 105
Des Moines 71
New York 67
Ho Chi Minh City 63
Dakar 61
San Mateo 59
São Paulo 58
Milan 57
Rome 55
Wilmington 51
Dong Ket 45
Nanchang 45
Hanoi 43
Washington 43
Saint Petersburg 41
Warsaw 37
Munich 36
Hebei 35
Helsinki 33
Tianjin 31
Ottawa 29
Palermo 29
Shenyang 29
Buffalo 28
Grafing 28
Tokyo 27
Council Bluffs 26
Lappeenranta 26
Cotonou 25
Seattle 24
Stockholm 23
Jiaxing 21
Montreal 21
The Dalles 21
Brooklyn 20
Brussels 20
Amsterdam 19
Bremen 19
Hong Kong 19
Poplar 19
Turku 19
Changsha 18
Kochi 18
Atlanta 17
Columbus 17
London 17
Denver 16
Rio de Janeiro 16
Johannesburg 15
Messina 15
Mexico City 15
Moscow 15
Tehran 15
Ankara 14
San Francisco 14
Boston 13
Naples 13
Redondo Beach 13
Bernareggio 12
Brno 12
Bronte 12
Guangzhou 12
Phoenix 12
Bari 11
Misterbianco 11
Mumbai 11
Orem 11
Chennai 10
Falls Church 10
Porto Alegre 10
Belo Horizonte 9
Charlotte 9
Dearborn 9
Genoa 9
Norwalk 9
Pune 9
Tashkent 9
Abuja 8
Totale 11.434
Salva come PNG Salva come JPEG
Nome #
Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy 246
Childhood neurofibromatosis type 2 (NF2) and related disorders: From bench to bedside and biologically targeted therapies [Neurofibromatosi tipo 2 (NF2) e sindromi correlate in età infantile: dalla biologia molecolare alla pratica clinica e nuove terapie con farmaci biologici] 246
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 185
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 169
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 159
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 152
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 151
"MESENTERIUM COMMUNE" IN GIOVANE ADULTO. UN RARO CASO CLINICO 151
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 147
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 144
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 136
A Phase III Study of Enoxaparin Vs Aspirin as Thromboprophylaxis for Newly Diagnosed Myeloma Patients Treated with Lenalidomide-Based Regimen 132
A Reciprocal Link between Oral, Gut Microbiota during Periodontitis: The Potential Role of Probiotics in Reducing Dysbiosis-Induced Inflammation 131
Focus on Osteosclerotic Progression in Primary Myelofibrosis 131
Hedgehog signaling pathways in multiple myeloma 123
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 123
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 122
Chk1 Inhibition Restores Inotuzumab Ozogamicin Citotoxicity in CD22-Positive Cells Expressing Mutant p53 121
A snapshot of asparaginase-induced liver insufficiency. 120
NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IMPROVES THE RISK ASSESSMENT OF ISS STAGING IN NEWLY DIAGNOSED MM PATIENTS TREATED UPFRONT WITH NOVEL AGENTS 120
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 120
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 118
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 115
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 113
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 113
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 112
A Real-Life Survey of Venous Thromboembolic Events Occurring in Myeloma Patients Treated in Third Line with Second-Generation Novel Agents 112
Mesenchymal stem cells (MSC) promotes tumor microenvironment transformation driving Granulocyte-like Myeloid Derived Suppressor Cells (G-MDSC) activation in Smoldering and Multiple Myeloma patients 111
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 110
ARGINASE 1 IS A MARKER OF MYELOID-MEDIATED IMMUNOSUPPRESSION WITH PROGNOSTIC MEANING IN CLASSIC HODGKIN'S LYMPHOMA 110
Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients 109
Absolute Count of Myeloid Derived Suppressor Cells (MDSC) Is Able to Predict the Response to Early-PET In Hodgkin Lymphoma 109
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 108
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 108
A case of high-risk AML in a patient with advanced systemic mastocytosis 107
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 107
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 105
Enhanced Antitumor Activity by the Combination of Dasatinib and Selinexor in Chronic Myeloid Leukemia 104
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 104
Myeloma Patient With Brugada Syndrome and Successful Lenalidomide Treatment 103
Belantamab Mafodotin and Relapsed/Refractory Multiple Myeloma: This Is Not Game Over 103
Bone turnover markers in patients with type 1 Gaucher disease 103
Acute GVHD after allogeneic hematopoietic transplantation affects early marrow reconstitution and speed of engraftment 102
Analysis of metabolic parameters coming from basal and interim PET in hodgkin lymphoma 101
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 100
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 97
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 97
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 96
CD200 EXPRESSION ON MYELOMA CELLS AND ANTITUMOR IMMUNITY 94
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 93
A rare case of multiple myeloma with intracranial extramedullary relapse: One or more myeloma clones? 93
Association of IMWG frailty score with health-related quality of life profile of patients with relapsed refractory multiple myeloma in Italy and the UK: a GIMEMA, multicentre, cross-sectional study 92
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 92
Broad copy neutral-loss of heterozygosity regions and rare recurring copy number abnormalities in normal karyotype-acute myeloid leukemia genomes 92
Multiple Myeloma in 2023 Ways: From Trials to Real Life 91
HIGH-RESOLUTION SNP ARRAYS AS AN ADDITIONAL TOOL TO SEARCH FOR GENETIC DEFECTS INVOLVED IN PROGRESSION FROM MYELODYSPLASTIC SINDROME TO ACUTE LEUKEMIA 90
CD200 expression in patients with multiple myeloma: Another piece of the puzzle 88
The Role of Dielectrophoresis for Cancer Diagnosis and Prognosis 88
The NLR and LMR ratio in newly diagnosed MM patients treated upfront with novel agents 87
Single segment of spleen autotransplantation, after splenectomy for trauma, can restore splenic functions 86
Brentuximab vedotin in association with bendamustine in refractory or multiple relapsed Hodgkin lymphoma. A retrospective real-world study 86
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 85
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 85
Saprochete capitata: Emerging Infections from Uncommon Microorganisms in Hematological Diseases 84
SMOLDERING MYELOMA: WALKING THROUGH RISK FACTORS AND TENTATIVE CLASSIFICATION SYSTEMS 84
Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network 83
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions 83
IMATINIB INCREASES CYTOTOXICITY OF MELPHALAN AND DECREASES PROLONGATION OF G2-M PHASE IN HUMAN K562 CELLS 83
Role of Serum Free Light Chain Assay in Relapsed/Refractory Multiple Myeloma. A Real-Life Unicentric Retrospective Study 82
Addressing Non-linear System Dynamics of Single-Strand RNA Virus-Host Interaction 82
Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey 82
NEUTROPHIL TO LYMPHOCYTE RATIO IMPROVES THE RISK ASSESSMENT OF ISS STAGING IN NEWLY DIAGNOSED MM PATIENTS TREATED UPFRONT WITH NOVEL AGENTS 82
Rate of fungal infections in patients with acute myeloid leukemia during induction treatment performing two prophylactic strategies: preliminary results 82
Bortezomib induced expression of heme oxygenase 1 via endoplasmic reticulum stress 19th Congress of the European-Hematology-Association. Milan, ITALY. Jun 12-15, 2014. 82
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 81
BROAD COPY NEUTRAL-LOSS OF HETEROZYGOSITY REGIONS AND RARE RECURRING COPY NUMBER ABNORMALITIES IN KARYOTYPICALLY NORMAL ACUTE MYELOID LEUKEMIA GENOMES 80
The Neutrophil-to-Lymphocyte Ratio is Related to Disease Activity in Relapsing Remitting Multiple Sclerosis 80
Advanced Stage Hodgkin Lymphoma: Patient Management 80
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 79
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 79
Bortezomib for the treatment of previously untreated multiple myeloma. 79
Detection of fungal dna in lysis-centrifugation blood culture for the prevision of response to antifungal in aml patients with persistent neutropenic fever: a pilot subset 79
HS-TROPONINE T RELATES WITH MYOCARDIAL IRON OVERLOAD IN TRANSFUSION DEPENDENT THALASSEMIC PATIENTS 78
Carbon nanotube-based sensing devices for human Arginase-1 detection 76
Monocytic Myeloid Derived Suppressor CELLS (M-MDSC) As Prognostic Factor in Chronic Myeloid Leukemia Patients Treated with Dasatinib 75
Immunological deregulation in classic hodgkin lymphoma. 75
THE ROLE OF SPARC IN CHRONIC MYELOID LEUKEMIA 75
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 75
Endoscopic features of gastro-intestinal lymphomas: From diagnosis to follow-up 75
Serum free light chains and multiple myeloma: Is it time to extend their application? 75
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 75
UP-REGULATION OF PROK-2/BV8 IN GRANULOCYTES IS PRESENT BOTH IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE AND MULTIPLE MYELOMA 74
Pomalidomide experience: an effective therapeutic approach with immunomodulatory drugs in a patient with relapsed-refractory multiple myeloma. 74
Troponine T as a marker of cardiac impairment in patients suffering thalassemia 74
Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens 74
Label-Free Enrichment of Circulating Tumor Plasma Cells: Future Potential Applications of Dielectrophoresis in Multiple Myeloma 73
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 73
Advances in understanding regulatory myeloid cells 72
Bone Turnover Markers In Gaucher Disease Patients 72
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 71
Totale 10.230
Salva come PNG Salva come JPEG
Categoria #
all - tutte 60.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 60.866
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021649 0 0 0 0 223 19 116 10 84 9 106 82
2021/20221.094 112 151 8 11 190 21 153 60 102 16 33 237
2022/20232.113 157 114 31 131 229 362 9 363 522 34 108 53
2023/20241.339 59 195 74 105 70 295 31 104 9 32 217 148
2024/20254.574 57 736 287 216 943 508 150 208 334 381 354 400
2025/20264.956 625 1.173 1.659 728 771 0 0 0 0 0 0 0
Totale 16.403